LAG3 Antikörper (Center)
Kurzübersicht für LAG3 Antikörper (Center) (ABIN2295942)
Target
Alle LAG3 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 103-132, Center
-
Kreuzreaktivität
- Human
-
Kreuzreaktivität (Details)
- Calculated cross reactivity: Hu
-
Produktmerkmale
- LAG-3 (Lymphocyte Activation Gene 3 Protein, LAG3, CD223, FDC, Protein FDC)
-
Aufreinigung
- Purified by Protein A affinity chromatography.
-
Immunogen
- KLH-conjugated synthetic peptide mapping to a fragment of residues within amino acids 103-132 in the central region of human LAG3, UniProt Accession #P18627.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working conditions should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, 0.09 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- -20°C
-
-
- LAG3 (Lymphocyte-Activation Gene 3 (LAG3))
-
Andere Bezeichnung
- LAG-3
-
NCBI Accession
- NP_002277
-
UniProt
- P18627
-
Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints
Target
-